Ms Debra A Scott, RN | |
215 N Main St, White River Junction, VT 05009-0001 | |
(802) 295-9363 | |
Not Available |
Full Name | Ms Debra A Scott |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 215 N Main St, White River Junction, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407939580 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | RN 225161 (California) | Primary |
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Debra A Scott, RN Po Box 520, Woodstock, VT 05091-0520 Ph: (802) 457-3991 | Ms Debra A Scott, RN 215 N Main St, White River Junction, VT 05009-0001 Ph: (802) 295-9363 |
News Archive
Before scientists can unlock the secrets of the human brain, they must fully understand neurons—the cells of our brain, spinal cord and overall nervous system. Thousands of detailed neuron images, from different organisms, currently sit in individual data collections across the globe, comprising several petabytes of data altogether.
The University of Granada will coordinate the European H2020 project "Smart Technologies for personAlised Nutrition and Consumer Engagement", a landmark initiative that was recently approved for €6.5 million in funding by the European Commission.
Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.
Researchers report on a Chicken-derived antibody against SARS-CoV-2, offering preliminary data on a potential therapeutic for COVID-19 warranting further research.
› Verified 4 days ago